Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска
Статья; ОбзорИскать документыПерейти к записи. 2018; Т. 10, № 1: 37–46. DOI:10.22328/2077-9828-2018-10-1-37-46
АНТИРЕТРОВИРУСНАЯ ТЕРАПИЯ - НОВАЯ ЭПОХА ПРОФИЛАКТИКИ ВИЧ-ИНФЕКЦИИ
Искать документыПерейти к записи[1]
Искать документыПерейти к записи[2]
Искать документыПерейти к записи[2,3]
Искать документыПерейти к записи[3]
Аффилированные организации
[1]Искать документыПерейти к записи
[2]Искать документыПерейти к записи
[3]Искать документыПерейти к записи
Аннотация
Ключевые слова
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Литература

Стратегия ЮНЭЙДС на 2016–2021 гг.: ускорение темпов борьбы со СПИДом // URL: http://www.unaids.org/ru/resources/documents/2015/UNAIDS_PCB37_15–18. [The UNAIDS strategy for 2016–2021: accelerating AIDS. URL: http://www.unaids.org/ru/resources/documents/2015/UNAIDS_PCB37_15–18 (In Russ.)].http://www.unaids.org/ru/resources/documents/2015/UNAIDS_PCB37_15–18

Стратегия ЮНЭЙДС на 2016–2021 гг.: ускорение темпов борьбы со СПИДом // URL: http://www.unaids.org/ru/resources/documents/2015/UNAIDS_PCB37_15–18. [The UNAIDS strategy for 2016–2021: accelerating AIDS. URL: http://www.unaids.org/ru/resources/documents/2015/UNAIDS_PCB37_15–18 (In Russ.)].http://www.unaids.org/ru/resources/documents/2015/UNAIDS_PCB37_15–18

Понимание подхода ЮНЭЙДС к ускорению мер: ускорение для искоренения эпидемии СПИДа к 2030 г. // URL: http://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_ru.pdf. [Understanding of UNAIDS approach to accelerate measures: acceleration of the eradication of the AIDS epidemic by 2030. URL: http://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_ru.pdf (In Russ.)].http://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_ru.pdf

Понимание подхода ЮНЭЙДС к ускорению мер: ускорение для искоренения эпидемии СПИДа к 2030 г. // URL: http://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_ru.pdf. [Understanding of UNAIDS approach to accelerate measures: acceleration of the eradication of the AIDS epidemic by 2030. URL: http://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_ru.pdf (In Russ.)].http://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_ru.pdf

Проекты глобальных стратегий сектора здравоохранения ВИЧ, 2016–2021 гг. 69-я Всемирная ассамблея здравоохранения, 2016 // URL: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-ru.pdf. [Draft global HIV health sector strategies, 2016–2021 69-th world health Assembly, 2016. URL: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-ru.pdf (In Russ.)].http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-ru.pdf

Проекты глобальных стратегий сектора здравоохранения ВИЧ, 2016–2021 гг. 69-я Всемирная ассамблея здравоохранения, 2016 // URL: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-ru.pdf. [Draft global HIV health sector strategies, 2016–2021 69-th world health Assembly, 2016. URL: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-ru.pdf (In Russ.)].http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_31-ru.pdf

Maheu-Giroux M., Vesga J.F., Diabaté S., Alary M., Baral S., Diouf D., Abo K., Boily M.C. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90–90–90 target in Côte d’Ivoire: Insights from mathematical modeling. PLoS Med., 2017, Vol. 14 (6), pp. e1002321. DOI: 10.1371/journal.pmed.1002321..
DOI: 10.1371/journal.pmed.1002321

Mathers B.M., Cooper D.A. Integrating HIV prevention into practice. JAMA, 2014, Vol. 312 (4), pp. 349–350. DOI: 10.1001/jama.2014.8606..
DOI: 10.1001/jama.2014.8606

Granich R., Gupta S., Hersh B., Williams B., Montaner J., Young B., Zuniga J.M. Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990–2013. PLoS One, 2015, Vol. 10 (7), pp. e0131353. DOI: 10.1371/journal.pone.0131353..
DOI: 10.1371/journal.pone.0131353

Global update on the health sector response to HIV. Geneva: WHO, July 2014, рр. 16.

Global AIDS Update UNAIDS. New York: United Nations, 2016, 16 p.

Cohen M.S., Smith M.K., Muessig K.E., Hallett T.B., Powers K.A., Kashuba A.D. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet, 2013, Vol. 382 (9903), pp. 1515–1524. DOI: 10.1016/S0140-6736(13)61998-4..
DOI: 10.1016/S0140-6736(13)61998-4

Plazy M., Farouki K.E., Iwuji C., Okesola N., Orne-Gliemann J., Larmarange J., Lert F., Newell M.L., Dabis F., Dray-Spira R.; Anrs 12249 Tasp Study Group. Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster- randomized trial in rural South Africa. J. Int. AIDS Soc., 2016, Vol. 19 (1), pp. 20 913. DOI: 10.7448/IAS.19.1.20913..
DOI: 10.7448/IAS.19.1.20913

Wilton J. & Broeckaert L. Treatment as prevention: do the individual prevention benefits translate of the population level? Prevention in Focus. PLoS Med., 2012, Vol. 9 (7), pp. e1001231. DOI: 10.1371/journal.pmed.1001231..
DOI: 10.1371/journal.pmed.1001231

Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach ARV2013. World Health Organization, 30 June 2013, 272 р.

Severe P., Juste M.A., Ambroise A., Eliacin L., Marchand C., Apollon S., Edwards A., Bang H., Nicotera J., Godfrey C., Gulick R.M., Johnson W.D. Jr., Pape J.W., Fitzgerald D.W. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N. Engl. J. Med., 2010, Vol. 363 (3), pp. 257–265. DOI: 10.1056/NEJMoa0910370..
DOI: 10.1056/NEJMoa0910370

Emery S., Neuhaus J.A., Phillips A.N., Babiker A., Cohen C.J., Gatell J.M., Girard P.M., Grund B., Law M., Losso M.H., Palfreeman A., Wood R. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J. Infect. Dis., 2008, Vol. 197 (8), pp. 1133–1144. DOI: 10.1086/586713..
DOI: 10.1086/586713

Kitahata M.M., Gange S.J., Abraham A.G., Merriman B., Saag M.S., Justice A.C., Hogg R.S., Deeks S.G., Eron J.J., Brooks J.T., Rourke S.B., Gill M.J., Bosch R.J., Martin J.N., Klein M.B., Jacobson L.P., Rodriguez B., Sterling T.R., Kirk G.D., Napravnik S., Rachlis A.R., Calzavara L.M., Horberg M.A., Silverberg M.J., Gebo K.A., Goedert J.J., Benson C.A., Collier A.C., Van Rompaey S.E., Crane H.M., McKaig R.G., Lau B., Freeman A.M., Moore R.D.; NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. N. Engl. J. Med., 2009, Vol. 360 (18), pp. 1815–1826. DOI: 10.1056/NEJMoa0807252..
DOI: 10.1056/NEJMoa0807252

Siedner M.J., Musinguzi N., Tsai A.C., Muzoora C., Kembabazi A., Weiser S.D., Bennett J., Hunt P.W., Martin J.N., Haberer J.E., Bangsberg D.R. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS, 2014, Vol. 28 (2), pp. 267–271. DOI: 10.1097/QAD.0000000000000136..
DOI: 10.1097/QAD.0000000000000136

Melo M.G., Santos B.R., De Cassia Lira R., Varella I.S., Turella M.L., Rocha T.M., Nielsen-Saines K. Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil. Sex. Transm. Dis., 2008, Vol. 35 (11), pp. 912–915. DOI: 10.1097/OLQ.0b013e31817e2491..
DOI: 10.1097/OLQ.0b013e31817e2491

Loutfy M.R., Wu W., Letchumanan M., Bondy L., Antoniou T., Margolese S., Zhang Y., Rueda S., McGee F., Peck R., Binder L., Allard P., Rourke S.B., Rochon P.A. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One, 2013, Vol. 8 (2), pp. e55747. DOI: 10.1371/journal.pone.0055747..
DOI: 10.1371/journal.pone.0055747

Castel A.D., Befus M., Willis S., Griffin A., West T., Hader S., Greenberg A.E. Use of the community viral load as a population-based biomarker of HIV burden. AIDS, 2012, Vol. 26 (3), pp. 345–353. DOI: 10.1097/QAD.0b013e32834de5fe..
DOI: 10.1097/QAD.0b013e32834de5fe

Sorensen S.W., Sansom S.L., Brooks J.T., Marks G., Begier E.M., Buchacz K., Dinenno E.A., Mermin J.H., Kilmarx P.H. A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS One, 2012, Vol. 7 (2), pp. e29098. DOI: 10.1371/journal.pone.0029098..
DOI: 10.1371/journal.pone.0029098

Birrell P.J., Gill O.N., Delpech V.C., Brown A.E., Desai S., Chadborn T.R., Rice B.D., De Angelis D. HIV incidence in men who have sex with men in England and Wales 2001–2010: a nationwide population study. Lancet Infect. Dis., 2013, Vol. 13 (4), pp. 313–318. DOI: 10.1016/S1473-3099(12)70341-9..
DOI: 10.1016/S1473-3099(12)70341-9

Wilson D.P. HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Med., 2012, Vol. 9 (7), pp. e1001231. DOI: 10.1371/journal.pmed.1001231..
DOI: 10.1371/journal.pmed.1001231

Wilson D.P. HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Med., 2012, Vol. 9 (7), pp. e1001231. DOI: 10.1371/journal.pmed.1001231..
DOI: 10.1371/journal.pmed.1001231

Van Griensven F., Guadamuz T.E., de Lind van Wijngaarden J.W., Phanuphak N., Solomon S.S., Lo Y.R. Challenges and emerging opportunities for the HIV prevention, treatment and care cascade in men who have sex with men in Asia Pacific. Sex. Transm. Infect., 2017, Vol. 93 (5), pp. 356–362. DOI: 10.1136/sextrans-2016–052669..
DOI: 10.1136/sextrans-2016–052669

Abu-Raddad L.J., Awad S.F. How does population viral load vary with the evolution of a large HIV epidemic in Sub-Saharan Africa? AIDS, 2014, Vol. 28 (6), pp. 927–929. DOI: 10.1097/QAD.0000000000000211..
DOI: 10.1097/QAD.0000000000000211

Novitsky V., Essex M. Using HIV viral load to guide treatment-for-prevention interventions. Curr. Opin. HIV AIDS, 2012, Vol. 7 (2), pp. 117–124. DOI: 10.1097/COH.0b013e32834fe8ff..
DOI: 10.1097/COH.0b013e32834fe8ff

Eyawo O., de Walque D., Ford N., Gakii G., Lester R.T., Mills E.J. HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect. Dis., 2010, Vol. 10 (11), pp. 770–777. DOI: 10.1016/S1473-3099(10)70189-4..
DOI: 10.1016/S1473-3099(10)70189-4

Vernazza P., Bernard E.J. HIV is not transmitted under fully suppressive therapy: The Swiss Statement — eight years later. Swiss Med. Wkly, 2016, 146: w14246. DOI: 10.4414/smw.2016.14246..
DOI: 10.4414/smw.2016.14246

Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., Meehan M.O., Lutalo T., Gray R.H. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med., 2000, Vol. 342 (13), pp. 921–929.

Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C., Kumarasamy N., Hakim J.G., Kumwenda J., Grinsztejn B., Pilotto J.H., Godbole S.V., Mehendale S., Chariyalertsak S., Santos B.R., Mayer K.H., Hoffman I.F., Eshleman S.H., Piwowar-Manning E., Wang L., Makhema J., Mills L.A., de Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T.E., Nielsen-Saines K., Celentano D., Essex M., Fleming T.R. HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med., 2011, Vol. 365 (6), pp. 493–505. DOI: 10.1056/NEJMoa1105243..
DOI: 10.1056/NEJMoa1105243

Dieffenbach C.W. Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda. Curr. Opin. HIV AIDS, 2012, Vol. 7 (2):106–110. DOI: 10.1097/COH.0b013e32834f3f13..
DOI: 10.1097/COH.0b013e32834f3f13

Donnell D., Baeten J.M., Kiarie J., Thomas K.K., Stevens W., Cohen C.R., McIntyre J., Lingappa J.R., Celum C. Partners in Prevention HSV/HIV Transmission Study Team Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet, 2010, Vol. 375 (9731), pp. 2092–2098. DOI: 10.1016/S0140-6736(10)60705-2..
DOI: 10.1016/S0140-6736(10)60705-2

Jia Z., Mao Y., Zhang F., Ruan Y., Ma Y., Li J., Guo W., Liu E., Dou Z., Zhao Y., Wang L., Li Q., Xie P., Tang H., Han J., Jin X., Xu J., Xiong R., Zhao D., Li P., Wang X., Wang L., Qing Q., Ding Z., Chen R.Y., Liu Z., Shao Y. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet, 2013, Vol. 382 (9899), pp. 1195–1203. DOI: 10.1016/S0140-6736(12)61898-4..
DOI: 10.1016/S0140-6736(12)61898-4

Anglemyer A., Rutherford G.W., Horvath T., Baggaley R.C., Egger M., Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst. Rev., 2013, Vol. (4), pp. CD009153. DOI: 10.1002/14651858.CD009153.pub3..
DOI: 10.1002/14651858.CD009153.pub3

Das M., Chu P.L., Santos G.M., Scheer S., Vittinghoff E., McFarland W., Colfax G.N. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One, 2010, Vol. 5 (6), pp. e11068. DOI: 10.1371/journal.pone.0011068..
DOI: 10.1371/journal.pone.0011068

Montaner J.S., Lima V.D., Barrios R., Yip B., Wood E., Kerr T., Shannon K., Harrigan P.R., Hogg R.S., Daly P., Kendall P. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet, 2010, Vol. 376 (9740), pp. 532–539. DOI: 10.1016/S0140-6736(10)60936-1..
DOI: 10.1016/S0140-6736(10)60936-1

Nosyk B., Zang X., Min J.E., Krebs E., Lima V.D., Milloy M.J., Shoveller J., Barrios R., Harrigan P.R., Kerr T., Wood E., Montaner J.S.G. Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996–2013: a modelling study. Lancet HIV, 2017, Vol. 4 (7), pp. e303–e310. DOI: 10.1016/S2352-3018(17)30045-0..
DOI: 10.1016/S2352-3018(17)30045-0

Brown A.E., Kall M.M., Smith R.D., Yin Z., Hunter A., Hunter A., Delpech V.C. Auditing national HIV guidelines and policies: The United Kingdom CD4 Surveillance Scheme. Open AIDS J., 2012, Vol. 6, pp. 149–155. DOI: 10.2174/1874613601206010149..
DOI: 10.2174/1874613601206010149

Supervie V., Ndawinz J.D., Lodi S., Costagliola D. The undiagnosed HIV epidemic in France and its implications for HIV screening strategies. AIDS, 2014, Vol. 28 (12), pp. 1797–1804. DOI: 10.1097/QAD.0000000000000270..
DOI: 10.1097/QAD.0000000000000270

Supervie V., Costagliola D. Time for a revolution in tracking the HIV epidemic. Lancet HIV, 2016, Vol. 3 (8), pp. e337–e339. DOI: 10.1016/S2352-3018(16)30089-3..
DOI: 10.1016/S2352-3018(16)30089-3

Law M.G., Woolley I., Templeton D.J., Roth N., Chuah J., Mulhall B., Canavan P., McManus H., Cooper D.A., Petoumenos K. Trends in detectable viral load by calendar year in the Australian HIV observational database; Australian HIV Observational Database (AHOD). J. Int. AIDS Soc., 2011, Vol. 14, pp. 10. DOI: 10.1186/1758-2652-14-10..
DOI: 10.1186/1758-2652-14-10

Phillips A.N., Cambiano V., Nakagawa F., Brown A.E., Lampe F., Rodger A., Miners A., Elford J., Hart G., Johnson A.M., Lundgren J., Delpech V.C. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One, 2013, Vol. 8 (2), pp. e55312. DOI: 10.1371/journal.pone.0055312..
DOI: 10.1371/journal.pone.0055312

Mooney A.C., Gottert A., Khoza N., Rebombo D., Hove J., Suárez A.J., Twine R., MacPhail C., Treves-Kagan S., Kahn K., Pettifor A. Men’s Perceptions of Treatment as Prevention in South Africa: Implications for Engagement in HIV Care and Treatment. AIDS Educ. Prev., 2017, Vol. 29 (3), pp. 274–287. DOI: 10.1521/aeap.2017.29.3.274..
DOI: 10.1521/aeap.2017.29.3.274

Van Sighem A., Vidondo B., Glass T.R., Bucher H.C., Vernazza P., Gebhardt M., de Wolf F., Derendinger S., Jeannin A., Bezemer D., Fraser C., Low N. Swiss HIV Cohort Study. Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PLoS One, 2012, Vol. 7 (9), pp. e44819.

Cowan S.A., Gerstoft J., Haff J., Christiansen A.H., Nielsen J., Obel N. Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex. J. Acquir. Immune Defic. Syndr., 2012, Vol. 61 (1), pp. 106–111. DOI: 10.1097/QAI.0b013e31825af890..
DOI: 10.1097/QAI.0b013e31825af890

Lou J., Blevins M., Ruan Y., Vermund S.H., Tang S., Webb G.F., Shepherd B.E., He X., Lu H., Shao Y., Qian H.Z. Modeling the impact on HIV incidence of combination prevention strategies among men who have sex with men in Beijing, China. PLoS One, 2014, Vol. 9 (3), pp. e90985. DOI: 10.1371/journal.pone.0090985..
DOI: 10.1371/journal.pone.0090985

Lou J., Hu P., Qian H.Z., Ruan Y., Jin Z., Xing H., Shao Y., Vermund S.H. Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China. PLoS One, 2017, Vol. 12 (4), pp. e0171295. DOI: 10.1371/journal.pone.0171295..
DOI: 10.1371/journal.pone.0171295

Hu X., Chen F., Ding F., Lin X., Wang X., He H., Huang W., Yang Q., Zhang H. Coverage of HIV related follow-up intervention and antiretroviral treatment and its correlation among HIV-positive men who have sex with men of 3 cities in China. Zhonghua Yu Fang Yi Xue Za Zhi (Chinese), 2015, Vol. 49 (11), pp. 945–949.

Su S., Chen X., Mao L., He J., Wei X., Jing J., Zhang L. Superior Effects of Antiretroviral Treatment among Men Who have Sex with Men Compared to Other HIV At-Risk Populations in a Large Cohort Study in Hunan, China. Int. J. Environ. Res. Public Health, 2016, Vol. 13 (3),

pii: E283. DOI: 10.3390/ijerph13030283..
DOI: 10.3390/ijerph13030283

Kroon E.D.M.B., Phanuphak N., Shattock A.J., Fletcher J.L.K., Pinyakorn S., Chomchey N., Akapirat S., de Souza M.S., Robb M.L., Kim J.H., van Griensven F., Ananworanich J., Wilson D.P. Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89[%] among men who have sex with men in Bangkok. J. Int. AIDS Soc., 2017, Vol. 20 (1), pp. 1–9. DOI: 10.7448/IAS.20.1.21708..
DOI: 10.7448/IAS.20.1.21708

Milloy M.J., King A., Kerr T., Adams E., Samji H., Guillemi S., Wood E., Montaner J. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting. J. Int. AIDS Soc., 2016, Vol. 19 (1), pp. 20 617. DOI: 10.7448/IAS.19.1.20617..
DOI: 10.7448/IAS.19.1.20617

Lake S., Kerr T., Capler R., Shoveller J., Montaner J., Milloy M.J. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada. Int. J. Drug Policy, 2017, Vol. 42, pp. 63–70. DOI: 10.1016/j.drugpo.2017.02.009..
DOI: 10.1016/j.drugpo.2017.02.009

Milloy M.J., Wood E., Kerr T., Hogg B., Guillemi S., Harrigan P.R., Montaner J. Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV- Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative. Clin. Infect. Dis., 2016, Vol. 62 (5), pp. 640–647. DOI: 10.1093/cid/civ929..
DOI: 10.1093/cid/civ929

Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Ермак Т.Н., Канестри В.Г., Шахгильдян В.И., Козырина Н.В., Воронин Е.Е., Афонина Л.Ю., Васильева И.А., Зимина В.Н. Национальные рекомендации по диспансерному наблюдению и лечению больных ВИЧ-инфекцией // Эпидемиология и инфекционные болезни. Актуальные вопросы. 2017. № 6, приложение. С. 1–80. [Pokrovskiy V.V., Yurin O.G., Kravchenko A.V., Belyaeva V.V., Ermak T.N., Kanestri V.G., Shahgildyan V.I., Kozyrina N.V., Voronin E.E., Afonina L.Yu., Vasil’eva I.A., Zimina V.N. National recommendations on dispensary surveillance and treatment of patients with HIV. Epidemiology and Infectious Diseases. Topical Issue, 2017, No. 6, Application, pp. 1–80 (In Russ.)].

Дополнительная информация
Язык текста: Русский
ISSN: 2077-9828
Унифицированный идентификатор ресурса для цитирования: //medj.rucml.ru/journal/4e432d4849562d41525449434c452d323031382d31302d312d302d33372d3436/